common.study.topics.clinical

Effects of Pau D' Arco in Primary Dysmenorrhea

common.study.values.description

Effects of Pau d' Arco in Primary Dysmenorrhea

A single arm, open-label trial evaluating safety and tolerability of encapsulated Tabebuia avellanedae in 12 generally healthy women aged 18-45 with primary dysmenorrhea (PDM). This will be the first study evaluating the safety and tolerability of Tabebuia avellanedae in PDM. We also aim to collect proof-of-concept mechanistic data supporting the hypothesis that Tabebuia avellanedae reduces PGE2 concentration in vivo in women with PDM.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Dietary Supplement - Pau d' Arco

Encapsulated herbal Pau d' Arco.

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Single Arm, Open-label Pilot Trial Examining the Effects of Pau d' Arco on Primary Dysmenorrhea in Reproductive Age Women

common.study.values.clinical-trial-id

NCT04245540

participant.views.study.view.id

dBBDnd